JAZZ News and Press, Jazz Pharmaceuticals plc From 06/14/24

2024-06-14 06:13:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips If this year’s market volatility has left you reeling, you’re not alone. But, despite the high valuations plaguing many tech stocks , plenty of top-tier, high-quality blue-c...

2024-06-12 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-05 11:34:16 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation Jazz Pharmaceuticals: Cheap But Complicated Jazz presents additional p...

2024-06-05 05:00:07 ET Andrea Tan from Goldman Sachs issued a price target of $169.00 for JAZZ on 2024-06-05 02:23:00. The adjusted price target was set to $169.00. At the time of the announcement, JAZZ was trading at $104.48. The overall price target consensus is at $20...

2024-06-01 17:13:06 ET More on Jazz Pharmaceuticals Jazz Pharmaceuticals: Cheap But Complicated Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug (u...

Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 PR Newswire Zanidatamab demonstrated a median overall survival (OS) of 15.5 month...

Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 PR Newswire Thirteen abstracts, including five late-breaking abstracts, underscore Jazz's ongoing commitment to advancing the understanding and treatment of serious sleep disorders Oral ...

Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire DUBLIN , May 29, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences...

Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer PR Newswire Target Action (PDUFA) Date set for November 29, 2024 If approved, zanidatamab will be the first HER2-targeted treatment specifically indicated for patients with HER2+ ...

2024-05-26 10:09:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many ar...